Zogenix competitive analysis

Latest publications and patents of Zogenix New

Explore the latest publications and patents granted to Zogenix, showcasing their recent innovations and technological advancements.

Last updated on: Sep 24, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Zogenix

Mar 13, 2024Methods Of Treating Lennox-Gastaut Syndrome Using FenfluramineGranted And Under Opposition
Oct 20, 2021Control System For Control Of Distribution Of MedicationRevoked
Dec 9, 2020Fenfluramine Compositions And Methods Of Preparing The SameGranted And Under Opposition

Explore Zogenix's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Mar 13, 2024Methods Of Treating Lennox-Gastaut Syndrome Using Fenfluramine1
Oct 20, 2021Control System For Control Of Distribution Of Medication1
Dec 9, 2020Fenfluramine Compositions And Methods Of Preparing The Same2

Latest PTAB cases involving Zogenix

Discover the latest PTAB cases involving Zogenix, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Zogenix with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ZOGENIX - 4 - - Non-Active
ELKINGTON AND FIFE85 - - - Highly Aggressive
KRAUS & LEDERER PARTGMBB67 - - - Highly Aggressive
OLON11 - - Aggressive